 |
0 Diseases |  |
70 Trials |
|
70 Trials |  |
3689 News |  |
| «12...70717273747576777879808182» |
- ||||||| olanzapine/fluoxetine / Generic mfg., fluoxetine / Generic mfg.
Trial completion, Enrollment change: A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression (clinicaltrials.gov) - Jan 16, 2016
P3, N=176, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Completed | N=229 --> 176
- New trial: TSOS6: A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=960, Recruiting, Sponsor: University of Washington
- Savella (milnacipran) / AbbVie, Pierre Fabre
Biomarker, Trial primary completion date: Predict Antidepressant Responsiveness Using Pharmacogenomics (clinicaltrials.gov) - Dec 31, 2015
P=N/A, N=1000, Recruiting, Sponsor: Samsung Medical Center
Recruiting --> Completed | N=229 --> 176 Trial primary completion date: Dec 2015 --> Dec 2018
- Savella (milnacipran) / AbbVie, Pierre Fabre
Biomarker, Trial primary completion date: Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients (clinicaltrials.gov) - Dec 31, 2015
P=N/A, N=1000, Recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Dec 2015 --> Dec 2018 Trial primary completion date: Dec 2015 --> Dec 2018
- Savella (milnacipran) / AbbVie, Pierre Fabre
Enrollment closed, Trial primary completion date: Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients (clinicaltrials.gov) - Dec 31, 2015
P=N/A, N=300, Active, not recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Dec 2015 --> Dec 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2018
- fluoxetine / Generic mfg.
Biomarker, Enrollment closed, Enrollment change, HEOR: FLAME: 16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression (clinicaltrials.gov) - Dec 16, 2015
P4, N=400, Active, not recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2018 Recruiting --> Active, not recruiting | N=600 --> 400
- Retrospective data, Trial primary completion date: Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=8800, Active, not recruiting, Sponsor: prof. Peter de Jonge
Recruiting --> Active, not recruiting | N=600 --> 400 Trial primary completion date: Jul 2015 --> Mar 2016
- fluoxetine / Generic mfg.
Trial completion, Enrollment change: A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture (clinicaltrials.gov) - Dec 6, 2015
P=N/A, N=36, Completed, Sponsor: The University of Hong Kong
Trial primary completion date: Jul 2015 --> Mar 2016 Recruiting --> Completed | N=82 --> 36
- fluoxetine / Generic mfg.
New trial: Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder (clinicaltrials.gov) - Nov 11, 2015
P=N/A, N=10, Not yet recruiting, Sponsor: Tang-Du Hospital
- fluoxetine / Generic mfg.
New trial: Deep Brain Stimulation of Nucleus Accumbens to Treat Severe Anorexia Nervosa (clinicaltrials.gov) - Nov 2, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: Tang-Du Hospital
- | New P4 trial: JFR: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana (clinicaltrials.gov) - Nov 2, 2015
P4, N=139, Completed, Sponsor: University of Ghana Medical School
- | fluoxetine / Generic mfg.
Enrollment open: Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? (clinicaltrials.gov) - Oct 29, 2015
P3, N=300, Recruiting, Sponsor: Cairo University
Recruiting --> Completed | N=82 --> 36 Not yet recruiting --> Recruiting
- lamotrigine liquid oral suspension / OWP Pharma
Trial completion, Enrollment change, Trial primary completion date: EDIPP: Early Detection and Intervention for the Prevention of Psychosis (clinicaltrials.gov) - Oct 24, 2015
P=N/A, N=3337, Completed, Sponsor: Maine Medical Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=350 --> 3337 | Trial primary completion date: May 2012 --> May 2013
- fluoxetine / Generic mfg.
Trial primary completion date: PTAD: An Adaptive Treatment Strategy for Adolescent Depression (clinicaltrials.gov) - Oct 23, 2015
P1/2, N=45, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting --> Completed | N=350 --> 3337 | Trial primary completion date: May 2012 --> May 2013 Trial primary completion date: Nov 2015 --> Feb 2016
- fluoxetine / Generic mfg.
Enrollment open, Trial primary completion date: PTAD GIA: An Adaptive Treatment Strategy for Adolescent Depression-Continuation (clinicaltrials.gov) - Oct 23, 2015
P1/2, N=45, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Trial primary completion date: Nov 2015 --> Feb 2016 Suspended --> Recruiting | Trial primary completion date: Oct 2015 --> Feb 2016
- fluoxetine / Generic mfg.
Enrollment open: PTAD: An Adaptive Treatment Strategy for Adolescent Depression (clinicaltrials.gov) - Oct 8, 2015
P1/2, N=45, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Suspended --> Recruiting | Trial primary completion date: Oct 2015 --> Feb 2016 Suspended --> Recruiting
- || fluoxetine / Generic mfg.
New P3 trial: Efficacy of Fluoxetine Against Seizure-induced Central Apneas (clinicaltrials.gov) - Oct 7, 2015
P3, N=80, Recruiting, Sponsor: Hospices Civils de Lyon
- | fluoxetine / Generic mfg.
Trial completion: Relapse Prevention for Bipolar Type-II Disorder (clinicaltrials.gov) - Oct 5, 2015
P4, N=180, Completed, Sponsor: University of Pennsylvania
Suspended --> Recruiting No longer recruiting --> Completed
- || fluoxetine / Generic mfg.
New P3 trial: Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? (clinicaltrials.gov) - Sep 29, 2015
P3, N=300, Not yet recruiting, Sponsor: Cairo University
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - Sep 25, 2015
P4, N=40, Recruiting, Sponsor: University of Arkansas
No longer recruiting --> Completed Trial primary completion date: Aug 2015 --> Aug 2016
- Trial termination, Trial primary completion date: Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression (clinicaltrials.gov) - Aug 21, 2015
P4, N=104, Terminated, Sponsor: Hospital Universitari de Bellvitge
Trial primary completion date: Aug 2015 --> Aug 2016 Recruiting --> Terminated | Trial primary completion date: Oct 2014 --> Jul 2014; Difficulties in recruiting
- venlafaxine / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression (clinicaltrials.gov) - Aug 14, 2015
P4, N=200, Recruiting, Sponsor: Capital Medical University
Recruiting --> Terminated | Trial primary completion date: Oct 2014 --> Jul 2014; Difficulties in recruiting Trial primary completion date: Sep 2015 --> Sep 2016
- Trial primary completion date: Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications (clinicaltrials.gov) - Aug 14, 2015
P4, N=500, Recruiting, Sponsor: Centre Hospitalier Universitaire Vaudois
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Aug 2015 --> Dec 2016
- fluoxetine / Generic mfg.
Trial initiation date: Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF. (clinicaltrials.gov) - Aug 14, 2015
P4, N=45, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Trial primary completion date: Aug 2015 --> Dec 2016 Initiation date: Mar 2015 --> Sep 2015
- fluoxetine / Generic mfg.
Trial primary completion date: Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM) (clinicaltrials.gov) - Aug 13, 2015
P=N/A, N=64, Recruiting, Sponsor: University of Maryland
Initiation date: Mar 2015 --> Sep 2015 Trial primary completion date: Dec 2015 --> Jul 2016
- | fluoxetine / Generic mfg.
Enrollment open: Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome (clinicaltrials.gov) - Aug 1, 2015
P3, N=300, Recruiting, Sponsor: Cairo University
Trial primary completion date: Dec 2015 --> Jul 2016 Not yet recruiting --> Recruiting
- |||||| Fetzima (levomilnacipran ER) / Pierre Fabre, AbbVie
Enrollment open, Enrollment change: Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder (clinicaltrials.gov) - Jul 9, 2015
P3, N=660, Recruiting, Sponsor: Forest Laboratories
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | N=480 --> 660
- fluoxetine / Generic mfg.
Enrollment open, Trial primary completion date, HEOR: Comparison of Acupuncture and Fluoxetine on Quality of Life in Menopausal Women (clinicaltrials.gov) - Jul 9, 2015
P=N/A, N=140, Recruiting, Sponsor: Gonabad University of Medical Sciences
Not yet recruiting --> Recruiting | N=480 --> 660 Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2014 --> Oct 2016
- Viibryd (vilazodone) / AbbVie
Enrollment closed: Effects of Treatment on Decision-making in Major Depression (clinicaltrials.gov) - Jul 6, 2015
P4, N=100, Active, not recruiting, Sponsor: Emory University
Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2014 --> Oct 2016 Recruiting --> Active, not recruiting
- || fluoxetine / Generic mfg.
New P3 trial: Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome (clinicaltrials.gov) - Jul 2, 2015
P3, N=300, Not yet recruiting, Sponsor: Cairo University
- fluoxetine / Generic mfg.
Enrollment change: FDA BDD: Fluoxetine in Pediatric Body Dysmorphic Disorder (clinicaltrials.gov) - Jun 29, 2015
P4, N=43, Completed, Sponsor: Montefiore Medical Center
Recruiting --> Active, not recruiting N=17 --> 43
- New trial, Retrospective data: Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis (clinicaltrials.gov) - Jun 20, 2015
P=N/A, N=8800, Active, not recruiting, Sponsor: prof. Peter de Jonge
- Vyvanse (lisdexamfetamine) / Shionogi, Takeda
Trial primary completion date: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation (clinicaltrials.gov) - Jun 17, 2015
P2, N=50, Recruiting, Sponsor: University of California, Los Angeles
N=17 --> 43 Trial primary completion date: Jul 2015 --> Jul 2016
- fluoxetine / Generic mfg.
Enrollment change, Trial withdrawal: FLAN: Fluoxetine for Motor, Aphasia, and Neglect Recovery After Ischemic Stroke (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=0, Withdrawn, Sponsor: Spaulding Rehabilitation Hospital
Trial primary completion date: Jul 2015 --> Jul 2016 N=25 --> 0 | Recruiting --> Withdrawn
- fluoxetine / Generic mfg.
New trial: Acupuncture for Ischemic Post-stroke Depression (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=208, Not yet recruiting, Sponsor: Menghan Li
- citalopram / Generic mfg., fluoxetine / Generic mfg.
New P4 trial: Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging (clinicaltrials.gov) - Jun 16, 2015
P4, N=25, Recruiting, Sponsor: New York State Psychiatric Institute
- fluoxetine / Generic mfg.
Enrollment closed, Enrollment change: EFLUSTIM: "Evaluation by Transcranial Magnetic Stimulation of the Benefit of Fluoxetine on Motor Recovery After Stroke" (clinicaltrials.gov) - Jun 12, 2015
P=N/A, N=6, Active, not recruiting, Sponsor: Centre Hospitalier St Anne
N=25 --> 0 | Recruiting --> Withdrawn Recruiting --> Active, not recruiting | N=40 --> 6
- fluoxetine / Generic mfg.
Trial completion, Enrollment change: Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension (clinicaltrials.gov) - Jun 12, 2015
P2, N=6, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Active, not recruiting | N=40 --> 6 Recruiting --> Completed | N=10 --> 6
- Savella (milnacipran) / AbbVie, Pierre Fabre
Trial primary completion date: Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=300, Recruiting, Sponsor: Samsung Medical Center
Recruiting --> Completed | N=10 --> 6 Trial primary completion date: Dec 2007 --> Dec 2015
- Savella (milnacipran) / AbbVie, Pierre Fabre
Biomarker, Trial primary completion date: Predict Antidepressant Responsiveness Using Pharmacogenomics (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=1000, Recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Dec 2007 --> Dec 2015 Trial primary completion date: Jun 2010 --> Dec 2015
- Savella (milnacipran) / AbbVie, Pierre Fabre
Biomarker, Trial primary completion date: Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=1000, Recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Jun 2010 --> Dec 2015 Trial primary completion date: Dec 2008 --> Dec 2015
- Biomarker, Trial primary completion date: PG: Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=1000, Recruiting, Sponsor: Samsung Medical Center
Trial primary completion date: Dec 2008 --> Dec 2015 Trial primary completion date: Mar 2008 --> Dec 2016
- fluoxetine / Generic mfg.
Trial suspension: PTAD GIA: An Adaptive Treatment Strategy for Adolescent Depression-Continuation (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=45, Suspended, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Trial primary completion date: Mar 2008 --> Dec 2016 Recruiting --> Suspended
- fluoxetine / Generic mfg.
Trial suspension: PTAD: An Adaptive Treatment Strategy for Adolescent Depression (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=45, Suspended, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Suspended Recruiting --> Suspended
- Savella (milnacipran) / AbbVie, Pierre Fabre
Biomarker, Enrollment closed: Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=1000, Active, not recruiting, Sponsor: Samsung Medical Center
Recruiting --> Suspended Recruiting --> Active, not recruiting
- sertraline / Generic mfg., paroxetine / Generic mfg., fluoxetine / Generic mfg.
Enrollment closed: Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients (clinicaltrials.gov) - Jun 6, 2015
P=N/A, N=300, Active, not recruiting, Sponsor: Samsung Medical Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Visanne (dienogest) / Mochida, Bayer
Enrollment open: Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome (clinicaltrials.gov) - May 28, 2015
P3, N=210, Recruiting, Sponsor: Cairo University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Enrollment open, Trial initiation date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - May 8, 2015
P4, N=40, Recruiting, Sponsor: University of Arkansas
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Jan 2015
- fluoxetine / Generic mfg.
New trial: Pharmaco(Epi)Genetic Study of Obsessive-Compulsive Disorder (clinicaltrials.gov) - May 1, 2015
P=N/A, N=200, Recruiting, Sponsor: Severance Hospital
- |||||||||| Fetzima (levomilnacipran ER) / Pierre Fabre, AbbVie
New P3 trial: Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder (clinicaltrials.gov) - May 1, 2015
P3, N=480, Not yet recruiting, Sponsor: Forest Laboratories